27 - 28 July 2018
Queenstown, New Zealand

    Registration Open    

Sponsors


Bioshares Biotech Summit 2018
The 14th Bioshares Biotech Summit will be held in Queenstown, New Zealand, on 27 – 28 July, 2018. The Summit is organised by Bioshares, Australia's leading independent biotech investment publication.

Attendees are strongly advised to arrive on the Thursday (26 July) with the official Summit start at 1pm on Friday 21 July.

Registration & Program
Registration for the Summit is now open with a registration form available here. A conference program is now available (PROGRAM). In an intense two-day program, last year there were 25 speakers with 12 hours of conference sessions.  

Attendees
Last year's 180 attendees registered for the event including biotech CEOs, fund managers and retail investors. The Summit is also relevant for many of the supporting industry groups. Technology transfer and pharmaceutical licensing executives should also ensure it’s part of their calendar.

CEO Dinner - Fully booked
The CEO
Dinner will be held on Thursday 26 July at Millbrook. Bus to pick up CEOs from Rydges Hotel at 6pm, returning at 11pm. Note that this dinner is now fully booked with no further places available.

Location
The Summit is held in stunning Queenstown, New Zealand, accessed through direct 3 hour flights from Melbourne, Sydney and Brisbane. Queenstown delivers many benefits. The Summit’s location away from day-to-day routines encourages a very open and collegial spirit, enabling in-depth discussions and the opportunity to meet people in a relaxed and enjoyable environment. Partners and families can also enjoy Queenstown’s picturesque views, local skiing, choose from many adventure activities, and select from more than 200 eateries in this wonderful location.

Accommodation – Rydges Hotel
The conference will be held at the renovated Rydges Hotel in Queenstown. All Summit sessions will be held at Rydges, which is a 5 minute walk from town centre and a 20 minute taxi ride from the airport.

Rydges Hotel (+64 3 442 7600 or email) - the hotel is currently full although rooms may be available in the stylish QT hotel at rear (use same contact details)

To book accommodation at 'alpine chic' hotel St Moritz (2 min walk to Rydges) see website
Other hotels nearby include:
Novotel (in town centre, 8-10 min walk to Rydges, lower cost) see website
Heritage Hotel (10 min walk up Fernhill away from Rydges and 15 mins from town centre) see website
A cheaper rate may be available at these hotels at booking.com


Sponsorship
For groups interested in joining the event this year as a sponsor, please contact Mark Pachacz on +61 403 850 425 or email events@bioshares.com.au

Peasants Dinner
(Not part of the Bioshares Biotech Summit program)
A 'Peasants Dinner' is being coordinated for the Thursday evening at Saffron restaurant in Arrowtown, for those attending the Summit and are not attending the CEO Dinner. For enquiries about this dinner, please email Stuart Roberts from NDF Research.

Speaker List
Special Guest Speaker

Dr Jake Begun
Mater Research, University of Queensland

"The Role of the Microbiome in Health & Disease"

LISTED COMPANIES
Assoc Professor David Packham (CMO of Dimerix)
Arik Anderson (CEO of Adherium)
Hartley Atkinson (CEO of AFT Pharmaceuticals)
Brent Barnes (CEO of LBT Innovations)
Mark Diamond (CEO of Antisense Therapeutics)
Tom Duthy (Global Head of IR & Corp Development at Sirtex Medical)
Nick Ede, CTO of Imugene
Michelle Fraser (CEO of RHS)
James Garner (CEO of Kazia Therapeutic)
Rod Hannington (Director of Eagle Health)
Ralph Highnam (CEO of Volpara Health Technologies)
Mike McCormick, CEO of Osprey Medical
Dr Sue O'Connor (VP Neuroscience Research at Bionomics)
Gary Phillips (CEO of Pharmaxis)
Bob Proulx (CEO of Imagion)
Kate Quirke (CEO of MKM Health(Alcidion))
Peter Rowland (CEO of Micro-X)
Peta Slocombe (VP of Corporate Health at Medibio)
Rosalind Wilson (CEO of Factor Therapeutics)
PRIVATE COMPANIES
Hugh Alsop (CEO of Kinoxis)
Bryce Carmine (Chair & CEO of HaemaLogix)
Colin Denver (CEO of Speedx)
Matt Liddelow (CEO of Neuroscientific Biopharmaceuticals)
Blake Wills (CEO of Microba)